Traws Pharma to hold virtual meeting for stock split approval
- Special meeting scheduled for [ ], 2026
- Proposal to approve reverse stock split at 1-for-8 to 1-for-15 ratio
- Board recommends voting for both proposals
TRAW
Traws Pharma, Inc. SEC filings
Every EDGAR filing for Traws Pharma, Inc. (TRAW), newest first, with AI summaries and stories.
- Ticker
- TRAW
- CIK
- 1130598
- Latest filing
- Oct 8
Next: earnings expected ~Nov 16 · 10-Q expected ~Nov 16 (deadline Nov 16)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINEPRE 14ATraws Pharma, Inc.ONTXLIVE ROUTINESCHEDULE 13G/ATraws Pharma, Inc.ONTXLIVE Ownership stake disclosure by Ikarian Capital, LLC (amended)
Ikarian Capital, LLC, filed by
NOTABLE10-QTraws Pharma, Inc.ONTXLIVE ROUTINE8-KTraws Pharma, Inc.ONTXLIVE ROUTINESCHEDULE 13G/ATraws Pharma, Inc.ONTXLIVE Ownership stake disclosure by Squadron Capital Management LLC (amended)
Squadron Capital Management LLC, filed by
ROUTINESCHEDULE 13GTraws Pharma, Inc.ONTXLIVE Ownership stake disclosure by Sirenia Capital Management LP
Sirenia Capital Management LP, filed by
ROUTINESCHEDULE 13G/ATraws Pharma, Inc.ONTXLIVE Ownership stake disclosure by Adage Capital Management, L.P. (amended)
Adage Capital Management, L.P., filed by
ROUTINE8-KTraws Pharma, Inc.ONTXLIVE ROUTINE4Traws Pharma, Inc.ONTXLIVE Charles David Pauza, insider filing for ONTX
Charles David Pauza, reporting
ROUTINE4Traws Pharma, Inc.ONTXLIVE Werner Cautreels, insider filing for ONTX
Werner Cautreels, reporting
ROUTINE4Traws Pharma, Inc.ONTXLIVE Nikolay Savchuk, insider filing for ONTX
Nikolay Savchuk, reporting
ROUTINE4Traws Pharma, Inc.ONTXLIVE Jack E Stover, insider filing for ONTX
Jack E Stover, reporting
ROUTINE4Traws Pharma, Inc.ONTXLIVE 6 insider filings
Iain D. Dukes, insider filing for ONTX
Show all 6
- 4Insider filing for ONTX
- 4Insider filing for ONTX
- 4Insider filing for ONTX
- 4Insider filing for ONTX
- 4Insider filing for ONTX
- 4Insider filing for ONTX
Iain D. Dukes, reporting
ROUTINE8-KTraws Pharma, Inc.ONTXLIVE ROUTINE424B5Traws Pharma, Inc.ONTXLIVE ROUTINEEFFECTTraws Pharma, Inc.ONTXLIVE ROUTINE8-KTraws Pharma, Inc.ONTXLIVE ROUTINES-3Traws Pharma, Inc.TRAWLIVE ROUTINE8-KTraws Pharma, Inc.TRAWLIVE ROUTINE8-KTraws Pharma, Inc.TRAWLIVE ROUTINEARSTraws Pharma, Inc.TRAWLIVE ROUTINEDEFA14ATraws Pharma, Inc.TRAWLIVE ROUTINEDEF 14ATraws Pharma, Inc.TRAWLIVE ROUTINE8-KTraws Pharma, Inc.TRAWLIVE ROUTINE8-KTraws Pharma, Inc.TRAWLIVE ROUTINE424B5Traws Pharma, Inc.TRAWLIVE ROUTINEPRE 14ATraws Pharma, Inc.TRAWLIVE ROUTINEEFFECTTraws Pharma, Inc.TRAWLIVE ROUTINE424B3Traws Pharma, Inc.TRAWLIVE ROUTINESCHEDULE 13G/ATraws Pharma, Inc.TRAWLIVE Ownership stake disclosure by PERCEPTIVE ADVISORS LLC (amended)
PERCEPTIVE ADVISORS LLC, filed by
ROUTINESCHEDULE 13G/ATraws Pharma, Inc.TRAWLIVE Ownership stake disclosure by Squadron Capital Management LLC (amended)
Squadron Capital Management LLC, filed by
NOTABLE10-QTraws Pharma, Inc.TRAWLIVE ROUTINE8-KTraws Pharma, Inc.TRAWLIVE ROUTINES-3Traws Pharma, Inc.TRAWLIVE NOTABLESCHEDULE 13D/ATraws Pharma, Inc.TRAWLIVE Ownership stake disclosure by ORBIMED ADVISORS LLC (amended)
ORBIMED ADVISORS LLC, filed by
ROUTINE10-K/ATraws Pharma, Inc.TRAWLIVE ROUTINE4Traws Pharma, Inc.TRAWLIVE ORBIMED ADVISORS LLC, insider filing for TRAW
ORBIMED ADVISORS LLC, reporting · OrbiMed Capital GP VIII LLC, reporting
NOTABLE10-KTraws Pharma, Inc.TRAWLIVE ROUTINE8-KTraws Pharma, Inc.TRAWLIVE ROUTINE8-KTraws Pharma, Inc.TRAWLIVE ROUTINE4Traws Pharma, Inc.TRAWLIVE 2 insider filings
Charles Nolan Parker, insider filing for TRAW
Show all 2
- 4Insider filing for TRAW
- 3New insider at TRAW
Charles Nolan Parker, reporting
NOTABLENT 10-KTraws Pharma, Inc.TRAWLIVE ROUTINE4Traws Pharma, Inc.TRAWLIVE 2 insider filings
Werner Cautreels, insider filing for TRAW
Show all 2
- 4Insider filing for TRAW
- 4Insider filing for TRAW
Werner Cautreels, reporting